The immunocytokine L19-IL2: An interplay between radiotherapy and long-lasting systemic anti-tumour immune responses

Recently, we have shown that the administration of the tumour-targeted antibody-based immunocytokine L19-IL2 after radiotherapy (RT) resulted in synergistic anti-tumour effect. Here we show that RT and L19-IL2 can activate a curative abscopal effect, with a long-lasting immunological memory. Ionizin...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncoimmunology
Asıl Yazarlar: Rekers, Nicolle H., Olivo Pimentel, Veronica, Yaromina, Ala, Lieuwes, Natasja G., Biemans, Rianne, Zegers, Catharina M. L., Germeraad, Wilfred T. V., Van Limbergen, Evert J., Neri, Dario, Dubois, Ludwig J., Lambin, Philippe
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2018
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5889197/
https://ncbi.nlm.nih.gov/pubmed/29632732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1414119
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller